Stotsky B A
Dis Nerv Syst. 1977 Dec;38(12):967-73.
In this double-blind study, haloperidol (n = 15) and thiothixene (n = 15), administered parenterally in emergency rooms and outpatient facilities to 30 acutely excited, agitated psychotic patients in hourly doses of 4 mg. or 8 mg., as needed over a four-hour period (total dosage ranging from 4 to 32 mg.), achieved rapid tranquilization in 30 patients. Significant improvement was shown over a six-hour period on BPRS Total Score, the four factors--Thinking Disorder, Anergic state, Excitement and Disorientation, and Depression and also on hourly ratings of 17 symptoms of a Psychiatric Target Symptom Profile. No significant differences were found between the haloperidol-treated and thiothixene-treated groups. Few adverse reactions were noted, all of them mild, the most frequent being drowsiness in six patients.
在这项双盲研究中,将氟哌啶醇(n = 15)和硫利达嗪(n = 15)通过肠胃外途径在急诊室和门诊设施中给予30名急性兴奋、躁动的精神病患者,每小时剂量为4毫克或8毫克,在4小时内根据需要给药(总剂量范围为4至32毫克),30名患者均实现了快速镇静。在6小时期间,两组患者在简明精神病评定量表总分、思维障碍、无活力状态、兴奋和定向障碍、抑郁这四个因子以及精神科目标症状谱的17种症状的每小时评分方面均有显著改善。氟哌啶醇治疗组和硫利达嗪治疗组之间未发现显著差异。记录到的不良反应很少,均为轻度,最常见的是6名患者出现嗜睡。